The minimally conscious state: definition and diagnostic criteria
Objective: To establish consensus recommendations among health care specialties for defining
and establishing diagnostic criteria for the minimally conscious state (MCS). Background…
and establishing diagnostic criteria for the minimally conscious state (MCS). Background…
Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the …
RG Miller, JA Rosenberg, DE Gelinas… - … and neural repair, 1999 - journals.sagepub.com
As with other chronic neurologic diseases, many of the problems engendered by the disease
can be managed effectively with a beneficial impact on quality of life and m some mstances …
can be managed effectively with a beneficial impact on quality of life and m some mstances …
Diagnosis and management of concussion in sports
JP Kelly, JH Rosenberg - Neurology, 1997 - AAN Enterprises
Any sport has an inherent risk of injury. A balance must be reached between maintaining a
competitive edge in a sport and ensuring participant safety. Frequently the loss of objectivity …
competitive edge in a sport and ensuring participant safety. Frequently the loss of objectivity …
[PDF][PDF] IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.
…, TM Liles, I Royston, C Varns, J Rosenberg… - Journal of clinical …, 1997 - io.ctdm.org.cn
Purpose: To evaluate the safety, pharmacokinetics, andbiologic effect of multiple doses of
the chimeric anti-CD20 monoclonal antibody (mAb) IDEC-C2B8 in patients with relapsed B-…
the chimeric anti-CD20 monoclonal antibody (mAb) IDEC-C2B8 in patients with relapsed B-…
Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment
…, DG Maloney, RL Weaver, J Rosenberg… - Journal of clinical …, 2000 - ascopubs.org
PURPOSE: This phase II trial investigated the safety and efficacy of re-treatment with rituximab,
a chimeric anti-CD20 monoclonal antibody, in patients with low-grade or follicular non-…
a chimeric anti-CD20 monoclonal antibody, in patients with low-grade or follicular non-…
[PDF][PDF] Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and …
…, MR Grever, AJ Grillo-Lopez, J Rosenberg… - Journal of Clinical …, 2001 - Citeseer
Purpose: Rituximab has been reported to have little activity in small lymphocytic lymphoma (SLL)/chronic
lymphocytic leukemia (CLL) and to be associated with significant infusion-…
lymphocytic leukemia (CLL) and to be associated with significant infusion-…
Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment
JL Rubenstein, D Combs, J Rosenberg… - Blood, The Journal …, 2003 - ashpublications.org
Most lymphomas that involve the central nervous system are B-cell neoplasms that express
the cell surface molecule CD20. After intravenous administration, rituximab can be …
the cell surface molecule CD20. After intravenous administration, rituximab can be …
Using electroencephalography to study functional coupling between cortical activity and electromyograms during voluntary contractions in humans
Previous studies of neuronal oscillations in sensorimotor cortex in humans and primates have
observed rhythmic 15–30 Hz activity, which is correlated with motor output. In humans, this …
observed rhythmic 15–30 Hz activity, which is correlated with motor output. In humans, this …
An extended difference of coherence test for comparing and combining several independent coherence estimates: theory and application to the study of motor units …
AM Amjad, DM Halliday, JR Rosenberg… - Journal of neuroscience …, 1997 - Elsevier
Recently there has been an increase in the use of spectral methods for the analysis of
experimental data. These analytical methods allow the study of interactions between …
experimental data. These analytical methods allow the study of interactions between …
Towards a proteome-scale map of the human protein–protein interaction network
…, C Simon, M Boxem, S Milstein, J Rosenberg… - Nature, 2005 - nature.com
Systematic mapping of protein–protein interactions, or ‘interactome’ mapping, was initiated
in model organisms, starting with defined biological processes 1 , 2 and then expanding to …
in model organisms, starting with defined biological processes 1 , 2 and then expanding to …